About TAT11

The 11th International Symposium on Targeted Alpha Therapy (TAT11) will be held in Ottawa, Canada April 1-5th 2019. TAT11 is jointly organized by Canadian Nuclear Laboratories and TRIUMF. The 11th International Symposium on Targeted Alpha Therapy continues a successful series of international symposia on this topic initiated by the Joint Research Centre of the European Commission, including meetings in Karlsruhe (1997, 2000), Heidelberg (2002), Düsseldorf (2004), Aachen (2007), Toronto (2009), Berlin (2011), Oak Ridge (2013), Warsaw (2015) and Kanazawa (2017).


Introducing: The First Ever TAT Clinical Day!

With Targeted Alpha Therapy treatments beginning to hit the market, the clinical perspective has become an essential part of the TAT conversation.  That's why TAT 11 is proud to announce the first ever TAT Clinical Day, including an all-day clinical track featuring leading practitioners in the field.  Learn firsthand about the challenges and opportunities presented by Targeted Alpha Therapies from the world's top clinical experts. 

The Clinical Committee is accepting the submission of abstracts of oral and poster presentations for the Clinical Day. Click here for details



jim_watson6461f_5x7_300dpi.jpg

His Worship Mayor James A. Watson, City of Ottawa, invitation to TAT11. 

I look forward, with great anticipation, to the possibility of welcoming you and your families to Ottawa in 2019.

Contact

➤ OUR OFFICE

  • 286 Plant Road

  • Chalk River, Ontario, Canada K0J 1J0

➤ TAT11 Venue

CONTACT

  • Toll Free: 1-800-868-8776

  • International: (+1) 613-732-7068

  • TAT11@cnl.ca


motionmailapp.com
 

Join the conversation

Confirmed Events